 |
Joint Meeting of the Antiviral Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee
| Center |
Date |
Time |
Location |
| CDER |
October 29, 2008
|
8:00 a.m. - 5:00 p.m.
|
Hilton The Ballrooms
1750 Rockville Pike
Rockville, MD |
Agenda
The committee will provide advice on types of studies and trial designs needed for an influenza antiviral MedKit for the treatment or prophylaxis of pandemic influenza and discuss publicly the proposed development program that would support an application for such a MedKit. Issues such as the role of personal MedKits, home stockpiling, non-prescription availability of influenza medications, and interfaces of home readiness with public health systems, will be raised in the course of the discussions.
Meeting Materials
Links to meeting materials will be added as they become available.
Public Participation Information
Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee.
- Written submissions may be made to the contact person on or before October 15, 2008.
- Oral presentations from the public will be scheduled between approximately 1:30 p.m. and 2:30 p.m., October 29. Those desiring to make formal oral presentations should notify the contact person and submit a brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time requested to make their presentation on or before October 6, 2008.
Time allotted for each presentation may be limited. If the number of registrants requesting to speak is greater than can be reasonably accommodated during the scheduled open public hearing session, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session. The contact person will notify interested persons regarding their request to speak by October 7, 2008.
Contact Information
- Paul Tran
Center for Drug Evaluation and Research (HFD-21)
Food and Drug Administration
5600 Fishers Lane (for express delivery, Fishers Lane, rm. 1093)
Rockville, MD 20857
301-827-7001
FAX: 301-827-6776
Email: paul.tran@fda.hhs.gov, or
- FDA Advisory Committee Information Line
1-800-741-8138(301-443-0572) in the Washington, DC area)
code 3014512531 and 301-4512541
Please call the Information Line for up-to-date information on this meeting.
A notice in the Federal Register about last minute modifications that impact a previously announced advisory committee meeting cannot always be published quickly enough to provide timely notice. Therefore, you should always check the agency’s Website and call the appropriate advisory committee hot line/phone line to learn about possible modifications before coming to the meeting.
FDA intends to make background material available to the public no later than 2 business days before the meeting. If FDA is unable to post the background material on its Web site prior to the meeting, the background material will be made publicly available at the location of the advisory committee meeting, and the background material will be posted on FDA’s Web site after the meeting.
Persons attending FDA’s advisory committee meetings are advised that the agency is not responsible for providing access to electrical outlets. FDA welcomes the attendance of the public at its advisory committee meetings and will make every effort to accommodate persons with physical disabilities or special needs. If you require special accommodations due to a disability, please contact Paul Tran at (301) 827-7001 at least 7 days in advance of the meeting. FDA is committed to the orderly conduct of its advisory committee meetings.
Please visit our Web site at http://www.fda.gov/oc/advisory/default.htm for procedures on public conduct during advisory committee meetings.
Notice of this meeting is given under the Federal Advisory Committee Act (5 U.S.C. app.2).
Advisory Committee Calendar
Advisory Commitee Home Page
 Back
to Top  Advisory Committee Home Page
 PDF requires the free Adobe Acrobat Reader
Date created: September 16, 2008; Updated: October 10, 2008 |
|
